FDAnews Drug Daily Bulletin

BIOACCELERATE ANNOUNCES NAME CHANGE, NEW STRATEGY AND PLANNED DISTRIBUTION TO SHAREHOLDERS

March 24, 2006
A A

Bioaccelerate Holdings, Inc today announced that it is has received majority shareholder approval to change its name to Gardant Pharmaceuticals, Inc. The Company also announced that it has adopted a new business strategy intended to increase overall shareholder value.
PrimeZone